Category

China

China: Guodian Technology & Environment Group, Chindata Group, AKM Industrial, Tencent, InnoCare Pharma Ltd, Uju Holding, Kwg Property Holding, Lanzhou Zhuangyuan Pasture and more

By | China, Daily Briefs

In today’s briefing:

  • Guodian Tech (1296 HK): Done Deal As Pre-Cons Fulfilled
  • Chindata the Next Chinese ADR Privatisation Target?
  • AKM Industrial’s Offer Risk/Reward – Pre-Condition Satisfied
  • Tencent 1Q2021 Earnings Preview: Earnings Weakness to Continue
  • InnoCare Pharma Ltd (9969.HK) – Lack of Clear Commercialization Prospects
  • Uju Holding IPO Lock-Up – Would Improve the Liquidity but We Wouldn’t Be Buyers
  • Morning Views Asia: KWG Living Group
  • Zhuangyuan Pasture (1533 HK): H-Share Offer Via Buyback

Guodian Tech (1296 HK): Done Deal As Pre-Cons Fulfilled

By David Blennerhassett

  • Guodian Technology & Environment Group (1296 HK)‘s (GTE) pre-cons are now fulfilled – bang in line with my timetable estimate.
  • The Composite Document should be despatched to the shareholders on or before 29 April 2022. 
  • Assuming all goes to plan – and there is every indication it will – payment under the Offer is expected around mid-June.

Chindata the Next Chinese ADR Privatisation Target?

By Arun George

  • A Bloomberg article claimed that Chindata Group (CD US) is attracting takeover interest from GDS Holdings (ADR) (GDS US), PAG and EdgeConneX. Shares rose 9.8% to close at $4.81.
  • Potential privatisation will require the blessing of Bain Capital, the largest shareholder. Chindata’s track record of beating guidance, modest leverage and the beaten-down rating make it a target. 
  • A forward EV/EBITDA multiple of 8.9x, in line with 21Vianet Group (VNET US)’s proposed acquisition multiple, would imply $6.85 per ADS. 

AKM Industrial’s Offer Risk/Reward – Pre-Condition Satisfied

By Arun George

  • AKM Industrial (1639 HK)’s privatisation offer from Alpha Luck and AKM Meadville of HK$1.8345 consists of a base offer (HK$1.82) and a final dividend (HK1.45 cent).
  • The pre-condition was fulfilled on 22 April. The latest date for the despatch of the scheme document has been extended to 10 June. 
  • Shareholders with blocking stakes have previously provided irrevocables. At last close and for an early-August effective date, the gross and annualised spread to the offer is 3.1% and 10.7%, respectively.

Tencent 1Q2021 Earnings Preview: Earnings Weakness to Continue

By Shifara Samsudeen, ACMA, CGMA

  • Tencent (700 HK) will announce its first quarter 2021 results on 18th May 2022.
  • Since 3Q2021, Tencent’s earnings have started to decelerate, and the previous quarter marked the slowest ever revenue growth for the company since 2004.
  • We expect Tencent’s earnings weakness to continue well into 1H2022E due to slowdown in online games and online advertising businesses.  

InnoCare Pharma Ltd (9969.HK) – Lack of Clear Commercialization Prospects

By Xinyao (Criss) Wang

  • InnoCare was approved to list in the SSE STAR Market, and the Company also released its improving financial performance in 2021. However, the outlook for InnoCare remains challenging and uncertain.
  • Either orelabrutinib or the pipeline, they don’t have pricing power due to lack of sufficient competitiveness and slower development progress, which means that their commercialization performance is highly uncertain.
  • There’s no definite commercialization outlook for InnoCare, with a far distance from becoming a biopharma. InnoCare was overvalued and could be attractive if the market value could be 50% off.

Uju Holding IPO Lock-Up – Would Improve the Liquidity but We Wouldn’t Be Buyers

By Clarence Chu

  • Uju Holding raised US$103m from its Hong Kong IPO in Nov 2021, where the IPO had been priced at the bottom end.
  • The offering was only mildly oversubscribed and the two cornerstones in the deal, Bytedance and Green Better (Xiaomi), had combined to subscribe to 12.6% of the offer shares
  • The cornerstones and Pre-IPO investors’ stake are coming up for lockup expiry. The latter will see half of their stakes unlocked, with the remainder locked up for another six months.

Morning Views Asia: KWG Living Group

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Zhuangyuan Pasture (1533 HK): H-Share Offer Via Buyback

By David Blennerhassett

  • PRC dairy farmer Lanzhou Zhuangyuan Pasture (1533 HK) has announced a Conditional Cash Offer for all H-shares at $10.89/share.
  • The Offer is being done via a Voluntary Cash Offer, therefore an onerous 90% tendering condition is present.
  • This transaction could potentially be wrapped up late-July. The FY21 dividend may also be added to terms. 

Before it’s here, it’s on Smartkarma

China: Hangzhou Tigermed Consulting (H), Cimc Enric Holdings, Kwg Property Holding and more

By | China, Daily Briefs

In today’s briefing:

  • Hangzhou Tigermed Consulting (3347.HK/300347.CH) – The Business Model May Not Be a Safe Play
  • CIMC Enric (3899 HK): A Favourable Start
  • Morning Views Asia: Delta Dunia Makmur, Jingrui Holdings, KWG Living Group

Hangzhou Tigermed Consulting (3347.HK/300347.CH) – The Business Model May Not Be a Safe Play

By Xinyao (Criss) Wang

  • Despite solid growth in 2021, if seen from prior years, the revenue YoY growth rate and net profit YoY growth rate showed a state of divergence, which is “interesting”.
  • Since half of Tigermed’s net profits were from investment income,it’s not logical to apply the valuation methods of traditional CXO to Tigermed. Its CRO and investment should be valued separately.
  • The poor IPO sentiment, risk of recession and the domestic healthcare rational return would make investors reconsider if Tigermed’s “CRO + PE/VC business model” would be a safe play.

CIMC Enric (3899 HK): A Favourable Start

By Osbert Tang, CFA

  • Cimc Enric Holdings (3899 HK) has an encouraging 1Q22 with 24.9% revenue growth. If not the impact of the pandemic and lockdowns in Mar, growth would even reach 35.2%.
  • Total new orders increased 23.2% in the quarter even in a period disrupted by lockdowns. Backlog stands at Rmb15.5bn, enough to fully cover FY22 revenue with 7% growth.
  • Hydrogen energy business, though still small, witnessed 80.5% revenue growth. Good demand drives new orders to Rmb105.4m; and its backlog of Rmb180m equals to 5x of 1Q22 revenue. 

Morning Views Asia: Delta Dunia Makmur, Jingrui Holdings, KWG Living Group

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: Guodian Technology & Environment Group and more

By | China, Daily Briefs

In today’s briefing:

  • Guodian Tech’s Offer Risk/Reward – Pre-Condition Satisfied

Guodian Tech’s Offer Risk/Reward – Pre-Condition Satisfied

By Arun George

  • Guodian Technology & Environment Group (1296 HK)’s privatisation offer from China Energy is HK$1.08 per H share. The pre-condition was fulfilled on 22 April.  
  • The key conditions for the delisting will be approval by at least 75% of independent H-shareholders (<10% of all independent H-shareholders rejection). There is no minimum acceptance condition.  
  • At last close and for a mid-June effective date (composite document despatched by 29 April), the gross and annualised spread to the offer is 2.9% and 19.9%, respectively.

Before it’s here, it’s on Smartkarma

China: Taste Gourmet Group, Jinxin Fertility Co Ltd, ASM Pacific Technology, China Construction Bank H, Agile Property Holdings, Zhenro Properties, American Electric Power and more

By | China, Daily Briefs

In today’s briefing:

  • A Comprehensive List of Hong Kong F&B Names to Play the Reopening
  • Jinxin Fertility: Shenzhen and Yunnan Acquisitions
  • ASMP (522.HK): 1Q22 Results and 2Q22 Forecast- A Warm up in 2022 and It Should Be Another Hike in 3Q
  • China Banks – 4Q21 KPIs Support Our Stock Picks
  • Weekly Wrap – 22 Apr 2022
  • Chinese Property Weekly – 22 April 2022 – Lucror Analytics
  • Chinese Property Weekly – 22 April 2022 – Lucror Analytics
  • Weekly Wrap – 22 Apr 2022
  • CLearBridge Investments Value Equity Strategy Q1 2022 Commentary

A Comprehensive List of Hong Kong F&B Names to Play the Reopening

By Sameer Taneja

  • HK F&B is set to have a reprieve as dine-in services at catering businesses can now remain open from 6 pm-10 pm ( max seating up to 4 people).
  • We provide a list of 34 names that will benefit from the removal of restrictions ( some with further catalysts down the road as they are exposed to China)
  • Our favorite pick remains Taste Gourmet Group (8371 HK) which we have written about in our insight Taste Gourmet: Multibagger Reopening Play.

Jinxin Fertility: Shenzhen and Yunnan Acquisitions

By Ke Yan, CFA, FRM

  • Jinxin announced in recent days that it further increases stake in Shenzhen Hospital, Jiuzhou Hospital and Hewanjia Hospital.
  • In this note, we analyze the impact on the company. We think the acquisition is sensible when the market sentiment is weak. 
  • We also summarize recent industry development and the company’s FY2021 results. We are turning relatively more bearish.

ASMP (522.HK): 1Q22 Results and 2Q22 Forecast- A Warm up in 2022 and It Should Be Another Hike in 3Q

By Patrick Liao

  • Revenue of HK$5.27 billion (US$674.8 million), +21.5% YoY and -15.1% QoQ, was at the high end of revenue guidance issued in 1Q22.
  • Revenue guidance was US$670 million to US$740 million, which was +5.8% YoY and +4.5% QoQ at mid-point in Q2 2022.
  • Usually, the 1st quarter is the weakest of the year. The booking magnitude might be showing how is the industry customers’ confidence now. 

China Banks – 4Q21 KPIs Support Our Stock Picks

By Victor Galliano

  • CCB is our preferred pick, given its attractive valuations, strong capital adequacy, healthy ROE and sound credit quality; CCB’s real estate exposure is limited and it sector delinquency is low
  • We also pick PSBC for its good value, its attractive PEG ratio and healthy credit quality and coverage; its real estate exposure, and its related delinquency, are both very low
  • We are negative on China Minsheng due to its low ROE, poor delinquency and NPL coverage, its high exposures to real estate relative to its peers and fast rising delinquency

Weekly Wrap – 22 Apr 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. China Jinmao Holdings
  2. Guangzhou R&F Properties
  3. Sunac China Holdings
  4. Greenland Hong Kong Holdings
  5. Evergrande

and more…


Chinese Property Weekly – 22 April 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Chinese Property Weekly – 22 April 2022 – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Weekly Wrap – 22 Apr 2022

By Charles Macgregor

Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.

In this Insight:

  1. China Jinmao Holdings
  2. Guangzhou R&F Properties
  3. Sunac China Holdings
  4. Greenland Hong Kong Holdings
  5. Evergrande

and more…


CLearBridge Investments Value Equity Strategy Q1 2022 Commentary

By Fund Newsletters

  • ClearBridge is a leading global asset manager committed to active management.
  • The market now has a clear call to action to solve the dual challenges of energy security and energy transition, requiring serious capital spending and innovation.
  • We added to defensive sectors including utilities and health care, looking for true diversification with low price correlations and lower price volatility.

Before it’s here, it’s on Smartkarma

China: Zhihu Technology, CATL (A), Cafe De Coral Holdings, Suchuang Gas Corp, PICC Property & Casualty H, JD.com Inc., Dongzheng Automotive Finance, Tencent Music, Zhenro Properties and more

By | China, Daily Briefs

In today’s briefing:

  • Zhihu HK Secondary Listing Trading – Delivered the Correction but Still Set for the Worst Debut Yet
  • CATL Sell-Off Wipes Out Billions of Dollars of Market Value
  • Hong Kong F&B: Stock Screening As Social-Distancing Curbs Ease
  • Suchuang Gas’ Privatisation Offer in Limbo as Additional Resumption Guidance Disclosed
  • FTSE China 50 Index Rebalance Preview: Two Changes Could Increase to Three
  • JD.com (9618) Support Break to Reach Our Buy Zone
  • Auction of China ZhengTong’s Dongzheng Stake Set for 18 May; Potential MGO
  • Dongzheng (2718 HK): 18th May Liquidation Of ZhengTong’s Stake
  • TME – ByteDance’s Launch of Music Streaming App to Add Further Pressure on Earnings
  • Morning Views Asia: Zhenro Properties

Zhihu HK Secondary Listing Trading – Delivered the Correction but Still Set for the Worst Debut Yet

By Sumeet Singh

  • Zhihu Technology (ZH US) raised around US$106m via a dual primary listing in Hong Kong. 
  • Unlike all the prior dual primary/secondary listings which have been done via offering either only primary or a mix of primary+secondary shares, Zhihu’s offering will consist of only secondary shares.
  • In this note, we’ll talk about the demand and trading dynamics.

CATL Sell-Off Wipes Out Billions of Dollars of Market Value

By Caixin Global

  • Skyrocketing material costs shook the stock of Contemporary Amperex Technology Co. Ltd. (CATL) as investors wiped billions of dollars off the value of the world’s largest electric-vehicle battery manufacturer.
  • Word circulated in the market that CATL is set to post net profit of less than 5 billion yuan for the first quarter, a sharp decline from the previous quarter.
  • The company hasn’t issued detailed financials for the fourth quarter and all of 2021. An estimate issued in January put annual net profit between 14 billion yuan and 16.5 billion yuan.

Hong Kong F&B: Stock Screening As Social-Distancing Curbs Ease

By David Blennerhassett

  • Hong Kong’s hospitality industry has endured three years of upheaval, first with the democracy protestors in 2019, which slowed inbound, followed by the onset of Covid in early 2020.
  • Beginning today, 21 April, the Government commenced the relaxation of most social distancing measures, to be eased over three phases.
  • This evolving dynamic is welcome, yet the progress and recovery for many operators may be gradual.

Suchuang Gas’ Privatisation Offer in Limbo as Additional Resumption Guidance Disclosed

By Arun George

  • CR Gas (1193 HK)’s privatisation bid for Suchuang Gas Corp (1430 HK) was derailed by the trading suspension due to the disclosure of previously unaccounted for pledges/guarantees by subsidiaries.
  • The controlling shareholders have attempted to keep the offer alive by agreeing to fully indemnify CR Gas for losses related to the pledges/guarantees.
  • The long stop date of the offer was extended to 31 August 2022. The key risk is that the timeframe to fulfil the resumption guidance exceeds the long stop date. 

FTSE China 50 Index Rebalance Preview: Two Changes Could Increase to Three

By Brian Freitas


JD.com (9618) Support Break to Reach Our Buy Zone

By Thomas Schroeder

  • JD.com met our 240+ short zone and has gapped below immediate 215 support, opening the way for  C wave decline to our target and buy zone near 180.
  • RSI trendline rejection sets up a slide to the sub 30 area which mean we will at least hit 180 if not reach for 160.
  • Holding the 160 low sets up an intermediate long trade. Be aware that there will be some wide tactical swing over the turbulent summer cycle.

Auction of China ZhengTong’s Dongzheng Stake Set for 18 May; Potential MGO

By Arun George

  • On 16 April, the Shanghai Financial Court published the details for the auction of China Zhengtong Auto Services Hldg (1728 HK)’s 71.04% stake in Dongzheng Automotive Finance (2718 HK)
  • If the auction is successful and results in any person and a group of persons acting in concert holding 30%+ of the voting rights, it will result in an MGO.
  • The base bid implies an MGO price of HK$1.294 per H Share, a 112.1% premium to the last close. The auction will be held from 18 May to 19 May.

Dongzheng (2718 HK): 18th May Liquidation Of ZhengTong’s Stake

By David Blennerhassett

  • After both stocks were suspended on the 19 April, the forced liquidation of China Zhengtong (1728 HK)‘s stake in Dongzheng (2718 HK) will occur, via auction, on the 18 May. 
  • That minimum bid price is HK$1.294/share, or a 112% premium to last close.
  • ZhengTong’s stake is 71.04% of shares out. A mandatory general offer – conditional or unconditional – may materialise from the auction process. 

TME – ByteDance’s Launch of Music Streaming App to Add Further Pressure on Earnings

By Shifara Samsudeen, ACMA, CGMA

  • Several news media outlets report that ByteDance has launched a new music streaming service in China called Qishui Yinyue.
  • Tencent Music (TME US) earnings have come under pressure with ending of exclusive music streaming licensing deals and increased regulatory pressure on its social entertainment biz.
  • We expect TME’s 1Q2022E earnings to decline further with increased competition and drop in social entertainment.

Morning Views Asia: Zhenro Properties

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: Dongzheng Automotive Finance, Tencent, Meituan, Sunac China Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • Dongzheng (2718 HK): Potential Offer As ZhengTong’s Stake Gets Liquidated
  • Tencent Needs to Break 350 to Meet Bear/Buy Targets
  • Meituan – Tear Sheet – Lucror Analytics
  • Morning Views Asia: Sunac China Holdings

Dongzheng (2718 HK): Potential Offer As ZhengTong’s Stake Gets Liquidated

By David Blennerhassett

  • Both Dongzheng Automotive Finance (2718 HK) and China Zhengtong Auto Services Hldg (1728 HK) issued HKEx suspension notices at the same time yesterday morning.
  • In no uncertain terms, the Shanghai office of the China Banking and Insurance Regulatory Commission has forced the liquidation of ZhengTong’s 71.04% stake in Dongzheng.
  • That stake “sale” may trigger an Offer for Dongzheng. Dongzheng’s suspension is “pursuant to the Hong Kong Code on Takeovers and Mergers“.

Tencent Needs to Break 350 to Meet Bear/Buy Targets

By Thomas Schroeder

  • Tencent short call at 390-400 is a hold but needs to break below the 351 low for bear traction toward our downside targets at 333 and 320 (bull zone).
  • The current flat/trapped range shows resistance at 382 and pivot support at 351/350. Below 350 would open the way lower.
  • Re test of the low zone is a buying opportunity for a rally to the 320-30 macro barrier. HK tech index sub 4k buy zone is our long counter balance.

Meituan – Tear Sheet – Lucror Analytics

By Charles Macgregor

We view Meituan as “Low Risk” on the LARA scale, given the company’s: [1] leading market positions in China’s food delivery as well as the in-store, hotel & travel accommodation industries; [2] increasing market share and scale, which should drive operating leverage; and [3] robust balance sheet, with net cash and a strong liquidity position. Meituan benefits from regulations that restrict aggressive pricing to gain market share. In addition, the company has fast-growing revenue streams across its business segments. However, the credit profile is weighed down by: [1] regulatory headwinds in the food delivery business; and [2] the ongoing losses and cash burn from the company’s community group-buying business.

Our Credit Bias is “Stable”, given the robust business risk profile and strong balance sheet.


Morning Views Asia: Sunac China Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: Melco International Development, Alibaba Group, DiDi Global, BYD, Shijiazhuang Yiling Pharmaceutical, China Energy Engineering, Hygeia Healthcare Group, ABM Investama, First Pacific Co and more

By | China, Daily Briefs

In today’s briefing:

  • StubWorld: Melco Trading Rich As Lawrence Adds To His Position
  • Alibaba Cloud: Exit of Senior Leadership Arouse Suspicion
  • Didi – A Quick Look at Latest Results Before Delisting
  • Byd (1211): Outperformer During Lockdown
  • Shijiazhuang Yiling Pharmaceutical (002603.CH) – Doubts About COVID-19 Drug and the Concerns Behind
  • Energy China (3996 HK): Multiple Drivers for Bright Prospects
  • Hygeia Healthcare Group (6078.HK) 2021 Results – Solid Business Logic Comes with Policy Risk
  • Asia HY Trade Book – April 2022 – Lucror Analytics
  • Morning Views Asia: China Vanke, First Pacific Co
  • Morning Views Asia: China Vanke, First Pacific Co

StubWorld: Melco Trading Rich As Lawrence Adds To His Position

By David Blennerhassett


Alibaba Cloud: Exit of Senior Leadership Arouse Suspicion

By Oshadhi Kumarasiri

  • Over the last year, we have highlighted some extremely damaging risks to Alibaba Group (9988 HK)’s cloud business.
  • The exit of senior leadership, right before the data migration deadline and the cybersecurity deal reassessment, arouse suspicion.
  • We suspect Alibaba could be using this “leadership reshuffle” to hide the reality of the Cloud business from investors.

Didi – A Quick Look at Latest Results Before Delisting

By Shifara Samsudeen, ACMA, CGMA

  • Didi on Monday announced that it will hold an EGM of shareholders on 23rd May for a vote on the voluntary delisting of the company’s ADS’ from the NYSE.
  • The company has mentioned that it will not apply for listing it shares on any other stock exchange before the completion of delisting.
  • Didi also has reported its 4Q2021 results and we take a look at the company’s recent results in this insight.

Byd (1211): Outperformer During Lockdown

By Henry Soediarko

  • BYD (1211 HK) is the most vertically integrated with its own chip manufacturing facility (BYD Semiconductor) and battery production unlike the rest of the Chinese auto OEMs.
  • The lockdown may not last that long as the Chinese authority is reportedly seeking to create a white list to resolve the supply chain issue.
  • It announced that Q1 22 net profit will range between RMB 650 to 950 million, an increase between 174% to 300% YoY which will make its forward PE cheaper. 

Shijiazhuang Yiling Pharmaceutical (002603.CH) – Doubts About COVID-19 Drug and the Concerns Behind

By Xinyao (Criss) Wang

  • There are doubts about the efficacy of Lianhua Qingwen to treat mild cases of COVID-19 in China, leading to the plunge of Yiling’s share price.
  • Fully evaluating the efficacy of Lianhua Qingwen requires larger double-blind randomized clinical trials. Data from other than double-blind controlled clinical trials are hard to be conclusive and can be controversial.
  • Even if Yiling could escape unscathed from the controversy, Yiling’s achievements since 2020 in capital market may not have sustainability.Together with the potential risks, investors are advised to remain cautious.

Energy China (3996 HK): Multiple Drivers for Bright Prospects

By Osbert Tang, CFA

  • We believe strong orders and backlog, increase in installed capacity and development of new business initiatives are the key drivers for brighter outlook of China Energy Engineering (3996 HK)
  • Its new orders grew 51% YoY in FY21, with its backlog is enough to cover the revenue more than the next three years mean solid earnings security and visibility.
  • Development of hydrogen energy and pumped storage businesses may take longer to contribute, but they also represent significant upside when enter into commercial launch. 

Hygeia Healthcare Group (6078.HK) 2021 Results – Solid Business Logic Comes with Policy Risk

By Xinyao (Criss) Wang

  • Driven by the development mode of “organic growth + strategic acquisitions + cooperation with hospital partners”, Hygeia Healthcare Group (6078 HK) could rapidly expand nationwide, with solid business logic. 
  • Hygeia’s delicacy management and the strength in operation help the Company to break the limits of the expansion of private hospitals, helping shorten the time it takes to break even.
  • However, the high uncertainties on policy and State’s attitude towards private hospitals cast shadow on Hygeia’s long-term prospects, but investors could still trade this stock in short term.

Asia HY Trade Book – April 2022 – Lucror Analytics

By Charles Macgregor

The Asia HY Trade Book for the month of April includes a summary of our recommendations, as well as our high-conviction ideas. The report also features relative-value charts and lists of the bonds in the Lucror Asia HY index.


Morning Views Asia: China Vanke, First Pacific Co

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Morning Views Asia: China Vanke, First Pacific Co

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: DiDi Global, Meituan, Tencent, Air China Ltd (H), Sino Biopharmaceutical, China Vanke, Kwg Property Holding and more

By | China, Daily Briefs

In today’s briefing:

  • DIDI Decides To Delist – Now It Gets Messy
  • DiDi to Vote on US Delisting on 23 May
  • Meituan Aligns Itself with Common Prosperity Measures but What Will Happen to Profitability?
  • Tencent: Investments up as Valuations Drop, Room for Another Significant Special in Specie Dividend
  • Air China (753 HK): Weaker 1Q22 Due to Exceptional Factors
  • Sino Biopharmaceutical (1177.HK) – Three “Golden Eggs” and the Risks Behind
  • China Vanke – Tear Sheet – Lucror Analytics
  • Morning Views Asia: KWG Living Group

DIDI Decides To Delist – Now It Gets Messy

By Travis Lundy

  • The company was told a year ago that it had data problems. It was then told in June it had serious data problems and was given 15 days to fix.
  • It did not. It listed itself, against the wishes of the regulators. Then it got in serious hot water. And it has only been getting hotter. 
  • A hoped-for HK Listing By Introduction was nixed 5 weeks ago. Now the Company is simply going to delist to try to solve its problems behind closed doors before relisting.

DiDi to Vote on US Delisting on 23 May

By Arun George

  • DiDi Global (DIDI US) will hold an EGM on 23 May to vote to delist the ADS from the NYSE. The shares will not be listed on another exchange before delisting. 
  • Due to the regulatory restrictions, DiDi is losing market share and pricing power to competitors in China. The 4Q21 results were poor. 
  • Directors and key pre-IPO investors together account for 48.2% of outstanding shares, suggesting that the ordinary resolution will pass. 

Meituan Aligns Itself with Common Prosperity Measures but What Will Happen to Profitability?

By Shifara Samsudeen, ACMA, CGMA

  • Nikkei reported that Meituan intends to pay better compensation to small-and-medium restaurants and to delivery workers to prove that the company is in line with Beijing’s common prosperity measures.
  • As Shanghai is under strict Covid lockdown, Meituan has seen a sharp rise in demand for grocery deliveries, however, margins are expected to be thin due to additional costs.
  • The company has been under tremendous pressure to improve its cost structure and is undertaking 10-20% job cuts across all its business units.

Tencent: Investments up as Valuations Drop, Room for Another Significant Special in Specie Dividend

By Wium Malan, CFA

  • Tencent’s increase in investment acquisition activity has coincided with a general weakness in equity prices and valuation levels.
  • Tencent management’s assessment of the fair value of its listed investee holdings, of RMB982.8bn on 31 December 2021, equates to roughly 27.4% of its market cap.
  • The market value of Tencent’s investee holdings in more-mature, Chinese-listed, internet-orientated holdings equates to roughly 9% of its current market cap.

Air China (753 HK): Weaker 1Q22 Due to Exceptional Factors

By Osbert Tang, CFA

  • Air China Ltd (H) (753 HK) has weaker passenger traffic in Mar and 1Q22 when compared with China Southern Airlines (1055 HK), and this is mostly due to the Olympics.
  • We expect one-off factors to remove starting Apr and traffic gap against CSA will narrow going forward. Its associate Cathay Pacific (293 HK) has also seen good pick-up in Mar. 
  • Air China outperformed CSA by 8pp YTD. There are signs of quarantine requirement relaxation for incoming passengers, and we anticipate gradual international traffic recovery to bode well for Air China.

Sino Biopharmaceutical (1177.HK) – Three “Golden Eggs” and the Risks Behind

By Xinyao (Criss) Wang

  • As the “the king of generics”, Sino Biopharmaceutical (1177 HK) is lucky to have three “golden eggs”(Entecavir, Anlotinib, CoronaVac) to contribute huge performance over the years.
  • The promotion of VBP and fierce competition make Sino Biopharmaceutical’s products lose pricing power. Due to little revolutionary technology/slow product iteration/weak R&D, it’s unlikely to have another Anlotinib level asset.
  • The Company’s development mode, the mindset of management, and other concerns could be more serious problems, causing investors to distrust the management level and preventing it from getting high valuation.

China Vanke – Tear Sheet – Lucror Analytics

By Charles Macgregor

We view China Vanke as “Low Risk” on the LARA scale, given the company’s: [1] leading market position in terms of sales and branding; [2] sound financial profile; and [3] diversified geographical coverage. Vanke is transitioning to become a more diversified company, with increased exposure outside the residential project sector and higher participation in the “Rail+Property” development model. Furthermore, the company is able to acquire land at lower cost amid the current bleak environment, and has lower financing costs due to its ties to the state.

Our fundamental Credit Bias on Vanke is “Stable”, given its adequate liquidity and sound credit metrics. We expect the company to have good access to funding, thanks to its status as a state-owned enterprise. That said, negative sentiment in the industry could weigh on Vanke’s performance.


Morning Views Asia: KWG Living Group

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: 21Vianet Group, Chongqing Zhifei Biological Products, Legend Biotech Corp, Central China Real Estate and more

By | China, Daily Briefs

In today’s briefing:

  • Merger Arb Mondays (18 Apr) – Yashili, VNET, Sezzle, Link Admin, Razer, Excelpoint, Guodian
  • Chongqing Zhifei Biological Products (300122.CH) – WHO’s One-Dose HPV Vaccine Regimen & The Outlook
  • Legend Biotech Corp (LEGN US): Carvykti Approval Is the Silver Lining Amid Uncertainty of Delisting
  • Morning Views Asia: Alam Sutera Realty, Anton Oilfield, Central China Securities, CIFI Holdings

Merger Arb Mondays (18 Apr) – Yashili, VNET, Sezzle, Link Admin, Razer, Excelpoint, Guodian

By Arun George


Chongqing Zhifei Biological Products (300122.CH) – WHO’s One-Dose HPV Vaccine Regimen & The Outlook

By Xinyao (Criss) Wang

  • Under the current policy in China, any minor changes to vaccine doses require a series of clinical data support and registration changes. So, WHO’s recommendation won’t affect Zhifei’s short-term performance.
  • The increasing domestic competing HPV vaccines in the future would be a big threat to Zhifei’s agency business. Its self-developed products may not be strong enough to compensate. 
  • The performance in 2022 is expected to be solid before real challenge comes in 2024. The valuation logic and outlook won’t be brighten unless there’s new breakthrough in agency business.

Legend Biotech Corp (LEGN US): Carvykti Approval Is the Silver Lining Amid Uncertainty of Delisting

By Tina Banerjee

  • Legend Biotech Corp (LEGN US) received FDA approval for its first product Carvykti in February as a fifth-line treatment of relapsed or refractory multiple myeloma.
  • Label expansion of Carvykti for earlier line of multiple myeloma treatments should expand addressable market, thereby increasing peak sales opportunity to $5 billion from initial expectation of $1.5 billion.
  • The U.S. Securities and Exchange Commission has added Legend to their delisting watchlist last week. The company needs to release required evidence by May 3 to stay listed.

Morning Views Asia: Alam Sutera Realty, Anton Oilfield, Central China Securities, CIFI Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma

China: JD.com Inc., GoTo and more

By | China, Daily Briefs

In today’s briefing:

  • Last Week in Event SPACE: JD.com, Suzuki, Twitter, Toyo Construction, Uniti Group, Singapore Press
  • ECM Weekly (17th Apr 2022)- Sk Shieldus, One Store, LIC, GoTo, Zhihu, Park24, PHC Holding, Visional

Last Week in Event SPACE: JD.com, Suzuki, Twitter, Toyo Construction, Uniti Group, Singapore Press

By David Blennerhassett

  • JD.com (9618 HK)‘s CCASS movements are a thing, and there are things going on in the background, but the things in the foreground are not as menacing as they appear. 
  • Suzuki Co Ltd (6785 JP)‘s NAV discount and implied stub plumb new lows. Again.
  • Musk has made a non-binding proposal for Twitter Inc (TWTR US) at US$54.20/share. Get it? Get it? Nudge nudge wink wink. That’s all part of the fun for him.

ECM Weekly (17th Apr 2022)- Sk Shieldus, One Store, LIC, GoTo, Zhihu, Park24, PHC Holding, Visional

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • On the IPOs front, Zhihu and the SK twins were the main active deals, with LIC being in the pipeline for a potential launch in the coming week.
  • Placement flows remained slow over the holiday shortened week. With Japan continuing to favour accelerated book build.

Before it’s here, it’s on Smartkarma